Medex confirms the efficiency of royal jelly in alleviating inflammation processes in the body for the first time ever

Medex plays one of the central roles in the world in upgrading the traditional use of bee products with clinically supported innovations. They have been investing in research for 6 decades now. Today, they develop safe and effective products in a modern laboratory, and they actively cooperate with public research institutions with their own registered R&D team. This was also the case with the research about the effects of royal jelly, with which Medex was the first in the world to confirm royal jelly’s efficiency in alleviating inflammation processes in the body.
 

The family-owned company Medex, which this year already celebrates its venerable 69 years of operation, is a pioneer of apitherapy in Slovenia and around the world, which means that bee products are used for therapeutic purposes. The company improves people's lives with natural, effective and innovative food supplements based on bee products. And Medex plays one of the central roles in the world in upgrading the traditional use of bee products with clinically supported innovations. "I am proud that for 60 years, Medex has been investing in the development of our state-of-the-art laboratory, where we develop innovative products based on bee products. When researching the effects of bee products, our registered R&D team also actively cooperates with public research institutions," said Vesna Virant, Director of Medex Trade and in charge of marketing and sales. Over ten employees work in the lab, of which four PhDs (two in the field of bee products).